4.7 Article

Genetic loss of SH2B3 in acute lymphoblastic leukemia

Journal

BLOOD
Volume 122, Issue 14, Pages 2425-2432

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2013-05-500850

Keywords

-

Categories

Funding

  1. Bonei Olam
  2. Innovative Research Award by the Stand Up to Cancer Foundation
  3. National Institutes of Health (ECOG Leukemia Tissue Bank) [CA21115, CA14958, CA17145]
  4. Rally Foundation

Ask authors/readers for more resources

The SH2B adaptor protein 3 (SH2B3) gene encodes a negative regulator of cytokine signaling with a critical role in the homeostasis of hematopoietic stem cells and lymphoid progenitors. Here, we report the identification of germline homozygous SH2B3 mutations in 2 siblings affected with developmental delay and autoimmunity, one in whom B-precursor acute lymphoblastic leukemia (ALL) developed. Mechanistically, loss of SH2B3 increases Janus kinase-signal transducer and activator of transcription signaling, promotes lymphoid cell proliferation, and accelerates leukemia development in a mouse model of NOTCH1-induced ALL. Moreover, extended mutation analysis showed homozygous somatic mutations in SH2B3 in 2 of 167 ALLs analyzed. Overall, these results demonstrate a Knudson tumor suppressor role for SH2B3 in the pathogenesis of ALL and highlight a possible link between genetic predisposition factors in the pathogenesis of autoimmunity and leukemogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available